Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Alesha J Smith"'
Autor:
Kyle J Wilby, Alesha J Smith
Publikováno v:
Journal of Primary Health Care, Vol 12, Iss 4, Pp 335-344 (2020)
Abstract INTRODUCTIONSexually transmitted infection (STI) rates continue to rise in New Zealand. To effectively prevent, test and diagnose STIs in a timely manner to limit their health effects, health services must be appropriate and accessible for a
Externí odkaz:
https://doaj.org/article/88838b6c41034774a3e90515a249e9d7
Publikováno v:
Journal of Pharmacy and Bioallied Sciences, Vol 8, Iss 3, Pp 173-180 (2016)
Introduction: Community pharmacists are in a suitable position to give advice and provide appropriate services related to sleep disorders to individuals who are unable to easily access sleep clinics. An intervention with proper objective measure can
Externí odkaz:
https://doaj.org/article/4369b8249e244b19a429ac3ef84a246e
Autor:
Connor Booker, Andrea L Murphy, Jennifer E. Isenor, Tasha D. Ramsey, Alesha J. Smith, Andrea Bishop, Deborah V. Kelly, Lisa Woodill, Greg Richard, Kyle John Wilby
Publikováno v:
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 156:137-149
Background: Pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) prevention is highly effective. Pharmacists can increase PrEP accessibility through pharmacist prescribing. This study aimed to determine pharmacists’ acceptance of
Pharmacist prescribing training models in the United Kingdom, Australia, and Canada: Snapshot survey
Publikováno v:
Pharmacy Education. 23:100-108
Background: This study sought to identify the differences between training models for pharmacist prescribing across three countries according to the funding, model of prescribing the pharmacist will practice after training, training course framework,
Autor:
Kyle J. Wilby, Alesha J. Smith
Publikováno v:
Pharmacy, Vol 8, Iss 2, p 84 (2020)
Pre-exposure prophylaxis (PrEP) for the human immunodeficiency virus (HIV) is rapidly increasing in use worldwide, with many countries now publicly funding use for high risk populations. Pharmacists, as front-line care providers, must have the necess
Externí odkaz:
https://doaj.org/article/ccac607e9212405da124115056b71c92
Publikováno v:
Archives of women's mental health. 24(4)
Women face complicated decisions regarding psychotropic medication use during pregnancy. Patient decision aids (PDAs) could be a valuable tool to assist with decision-making. The objective of this review was to evaluate the effectiveness of PDAs in t
Publikováno v:
The New Zealand medical journal. 127(1394)
Steadily rising rates of antimicrobial resistance, in a range of common bacterial pathogens, are a major threat to human health in New Zealand in the near future. The single largest contributor to this threat is the high level of antimicrobial consum
Publikováno v:
Journal of Primary Health Care, Vol 12, Iss 4, Pp 327-334 (2020)
ABSTRACT INTRODUCTIONDabigatran etexilate has become widely used in New Zealand, but information relating to when renal function monitoring is being undertaken is lacking. AIMTo investigate if clinically appropriate renal function monitoring is being
Externí odkaz:
https://doaj.org/article/13a61cca7271446fb7d8bfde50b40439
Publikováno v:
BMC Health Services Research, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Recently, New Zealand has taken a system wide approach providing the biggest reform to New Zealand community pharmacy for 70 years with the aim of providing more clinically orientated patient centred services through a new funding
Externí odkaz:
https://doaj.org/article/9acd79da2a194ba8bc7dc392305d3a8e
Publikováno v:
TH Open, Vol 03, Iss 03, Pp e210-e215 (2019)
Abstract Background Dabigatran etexilate has become widely used for the prevention of stroke in patients with nonvalvular atrial fibrillation (NVAF). Currently, there is limited information in real-world patients relating to dabigatran etexilate ex
Externí odkaz:
https://doaj.org/article/9fae1b536eac4845a8091b5dd27cb35f